Generics deals with Impax, Dr Reddy’s and Sagent aimed at satisfying competition authorities
$3.2bn purchase from Albemarle continues BASF’s efforts to expand and refocus its coatings division
Deal worth up to $1.25bn includes drug candidate for chronic coughs
$3.3bn deal expands Johnson & Johnson’s consumer products segment
UK trade bodies predominantly favour remaining in the EU
$1bn deal with Renaissance Acquisition Holdings brings 25 products and builds on Meda merger portfolio
€950m deal pushes French oil giant deeper into renewables
Will GSK's move towards licensing patents in developing countries, rather than rigidly defending them, improve access to medicines?
Company profile: Qpinch reclaims wasted energy by mimicking nature
Five others injured when wastewater treatment device detonated
Should trade bodies do more than simply 'represent their members' interests'?
Drug discovery startup will contribute to cancer immunotherapy projects aimed at kinase enzymes
Bringing history to the table
Could the debate over pharma price-gouging have positive results for both patients and companies?
Whistleblower case relates to claims of Wyeth overcharging for acid reflux drugs between 2001 and 2006
€475 million deal includes technology, products and sites in the UK and South Africa
UK Competition and Markets Authority deems pay-for-delay deal illegal and imposes £45m in fines
Allergan’s cancer drug generics do not infringe patents, say UK courts
Abbott to buy Alere for $5.8bn to augment its point-of-care diagnostics business
New drug adds new treatment options and increases competition in premium market
Cost-saving cuts will help ‘accelerate the pace of innovation’, company claims
Making it more attractive for companies to develop paediatric drugs has the potential to improve everyone’s lives
One dead and three injured in an equipment explosion at PeroxyChem in Texas
Deal boosts Thermo’s position in growing genomics field as well as adding antibodies and assay technology